Fractyl Health Files 8-K
Ticker: GUTS · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1572616
| Field | Detail |
|---|---|
| Company | Fractyl Health, Inc. (GUTS) |
| Form Type | 8-K |
| Filed Date | Jun 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, sec-filing, routine-report
TL;DR
Fractyl Health filed a standard 8-K, no major news.
AI Summary
Fractyl Health, Inc. filed an 8-K on June 18, 2025, reporting on other events and financial statements. The filing does not contain specific financial figures or details about new material events beyond the standard reporting requirements.
Why It Matters
This 8-K filing indicates routine corporate reporting by Fractyl Health, Inc. to the SEC, without disclosing new material information that would immediately impact investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not contain any new material information, significant financial changes, or operational updates that would indicate increased risk.
Key Players & Entities
- Fractyl Health, Inc. (company) — Registrant
- June 18, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 3 Van de Graaff Drive Suite 200 (address) — Principal Executive Offices
- Burlington, Massachusetts (location) — City and State of Principal Executive Offices
- 01803 (zip_code) — Zip Code of Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Fractyl Health, Inc.?
The primary purpose of this 8-K filing is to report on 'Other Events' and 'Financial Statements and Exhibits' as of June 18, 2025.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is June 18, 2025.
In which state is Fractyl Health, Inc. incorporated?
Fractyl Health, Inc. is incorporated in Delaware.
What is the principal executive office address for Fractyl Health, Inc.?
The principal executive office address for Fractyl Health, Inc. is 3 Van de Graaff Drive, Suite 200, Burlington, Massachusetts 01803.
Does this 8-K filing disclose any new material financial information or significant business developments?
Based on the provided text, this 8-K filing appears to be a routine report and does not explicitly disclose new material financial information or significant business developments beyond standard reporting categories.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding FRACTYL HEALTH, INC. (GUTS).